SARS-CoV-2 epitope-specific T cells: Immunity response feature, TCR repertoire characteristics and cross-reactivity
G Yang, J Wang, P Sun, J Qin, X Yang, D Chen… - Frontiers in …, 2023 - frontiersin.org
The devastating COVID-19 pandemic caused by SARS-CoV-2 and multiple variants or
subvariants remains an ongoing global challenge. SARS-CoV-2-specific T cell responses …
subvariants remains an ongoing global challenge. SARS-CoV-2-specific T cell responses …
Repositioning of Furin inhibitors as potential drugs against SARS-CoV-2 through computational approaches
A Saih, S Baammi, H Charoute, I Ettaki… - Journal of …, 2025 - Taylor & Francis
The recent spread of SARS-CoV-2 has led to serious concerns about newly emerging
infectious coronaviruses. Drug repurposing is a practical method for rapid development of …
infectious coronaviruses. Drug repurposing is a practical method for rapid development of …
Insights into the Interaction Mechanism of Boceprevir with SARS‐CoV‐2 Main Protease
The main protease (Mpro) of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐
2) is a prominent drug target as it plays a key role in viral replication and is greatly …
2) is a prominent drug target as it plays a key role in viral replication and is greatly …
[PDF][PDF] The effect of the emerging omicron variant on the willingness to take or continue with COVID-19 vaccination in the Middle East
The present study aimed to explore the willingness of the general public in the Middle East
area to take or continue with the available COVID-19 vaccine in light of the emergence of the …
area to take or continue with the available COVID-19 vaccine in light of the emergence of the …
Impact of COVID-19 on neuropsychiatric disorders
N Zia, P Ravanfar, S Allahdadian… - Journal of clinical medicine, 2022 - mdpi.com
Since the Coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), many studies have shown that besides …
respiratory syndrome coronavirus 2 (SARS-CoV-2), many studies have shown that besides …
Tea ingredients have anti-coronavirus disease 2019 (COVID-19) targets based on bioinformatics analyses and pharmacological effects on LPS-stimulated …
L Wang, Q Tao, Z Wang, J Shi, W Yan, L Zhang… - Frontiers in …, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is a contagious disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) that caused millions of deaths and lacks …
respiratory syndrome coronavirus 2 (SARS-CoV-2) that caused millions of deaths and lacks …
[PDF][PDF] The potential role of Gegen Qinlian decoction in the treatment of coronavirus disease 2019 based on network pharmacology and validation of …
L Wang, LY Wang, L Zhong, JF Shi, XM Yao… - Integr Med …, 2024 - tmrjournals.com
Abstract Background: Coronavirus disease 2019 (COVID-19) is caused by severe acute
respiratory syndrome coronavirus 2, which has led to deaths and currently lacks an efficient …
respiratory syndrome coronavirus 2, which has led to deaths and currently lacks an efficient …